One child, who was found to have osteochondroma of the right and left tibia six months after treatment, had growth hormone therapy discontinued, and regular follow‐up was recommended due to the PTPN11 mutation (Tajan et al., 2018). Here, PTPN11 is linked to Osteochondroma.